MAPT and Cognitive impairment: When paired, the combination of low CSF Aβ42 and high tau/ptau has been shown to be a strong predictor of future cognitive decline in both early symptomatic (very mild dementia or mild cognitive impairment, MCI) and asymptomatic individuals (55, 65–68).